clevercast
{"PEE04":{"id":"2M46na","strictid":"PEE04","name":"PEEK04 LIVE","description":"","account_id":"WxRD9M","ts":1607511600},"WEB04":{"id":"VDx0rX","strictid":"WEB04","name":"WEB04","description":"","account_id":"WxRD9M","ts":1607493600},"WEB03":{"id":"W9bamb","strictid":"WEB03","name":"WEB03","description":"","account_id":"WxRD9M","ts":1607407200},"WEB02":{"id":"Vv8ZyL","strictid":"WEB02","name":"WEB02","description":"","account_id":"WxRD9M","ts":1607320800},"WEB01":{"id":"Ww4n4n","strictid":"WEB01","name":"WEB01","description":"","account_id":"WxRD9M","ts":1607234400},"CLO01":{"id":"AG1BLq","strictid":"CLO01","name":"CLO01 LIVE","description":"Live Closing Ceremony\n","account_id":"WxRD9M","ts":1607533200},"LBR01":{"id":"ARXRzM","strictid":"LBR01","name":"LBR01 LIVE","description":"Live Late Breakers","account_id":"WxRD9M","ts":1607526000},"SCS08":{"id":"WdEw0P","strictid":"SCS08","name":"SCS08","description":"Co-infections in influenza, RSV disease and COVID-19","account_id":"WxRD9M","ts":1607518800},"SPI07":{"id":"A0wZ9y","strictid":"SPI07","name":"SPI07","description":"Burden of influenza, RSV disease and COVID-19 and impact on society","account_id":"WxRD9M","ts":1607518800},"SPI06":{"id":"WN4qrz","strictid":"SPI06","name":"SPI06","description":"Risk evaluation and communication strategies in influenza and COVID-19: lessons learned","account_id":"WxRD9M","ts":1607518800},"KEY08":{"id":"WEzP46","strictid":"KEY08","name":"KEY08","description":"Heidi Larsson","account_id":"WxRD9M","ts":1607518800},"KEY05":{"id":"WXwL5Z","strictid":"KEY05","name":"KEY05","description":"Neil Ferguson","account_id":"WxRD9M","ts":1607511600},"SCS12":{"id":"WgNYdo","strictid":"SCS12","name":"SCS12","description":"Animal influenza, ecology and epidemiology ","account_id":"WxRD9M","ts":1607511600},"SCS13":{"id":"258rEm","strictid":"SCS13","name":"SCS13","description":"Influenza, RSV disease and COVID-19 vaccination: current and future approaches ","account_id":"WxRD9M","ts":1607511600},"SAT05":{"id":"VeB17z","strictid":"SAT05","name":"SAT05 LIVE","description":" 05 LIVE ESPID\/ESWI supported by AZ","account_id":"WxRD9M","ts":1607504400},"GOM03":{"id":"21Olvv","strictid":"GOM03","name":"GOMO03 LIVE","description":"Goodmorning COLLIN","account_id":"WxRD9M","ts":1607500800},"MOR03":{"id":"Vr9bL3","strictid":"MOR03","name":"MORWEL03","description":"Morning welcome lecture ROCHE","account_id":"WxRD9M","ts":1607497200},"MEE02":{"id":"AZwZe5","strictid":"MEE02","name":"MEET02 + RECAP 3 LIVE","description":"Meet Collin and Marco live","account_id":"WxRD9M","ts":1607454000},"SAT06":{"id":"Wj19y6","strictid":"SAT06","name":"SAT06 LIVE","description":"Satellite Sanofi Pasteur","account_id":"WxRD9M","ts":1607446800},"SAT04":{"id":"24M69N","strictid":"SAT04","name":"SAT04 LIVE","description":"Satellite Roche","account_id":"WxRD9M","ts":1607439600},"KEY09":{"id":"2OLdM6","strictid":"KEY09","name":"KEY09","description":"Janina Krambach\n","account_id":"WxRD9M","ts":1607432400},"PEE03":{"id":"AkLxkJ","strictid":"PEE03","name":"PEEK03 LIVE","description":"","account_id":"WxRD9M","ts":1607432400},"SCS11":{"id":"Wq1BQ3","strictid":"SCS11","name":"SCS11","description":"Antiviral and immune therapy for influenza, RSV disease and COVID-19 ","account_id":"WxRD9M","ts":1607432400},"SCS10":{"id":"27EaP5","strictid":"SCS10","name":"SCS10","description":"Influenza, RSV disease and COVID-19 vaccination: current and future approaches ","account_id":"WxRD9M","ts":1607432400},"SCS09":{"id":"2bY8bw","strictid":"SCS09","name":"SCS09","description":"Threats and risk management of epidemics and pandemics ","account_id":"WxRD9M","ts":1607432400},"SAT08":{"id":"VPry6L","strictid":"SAT08","name":"SAT08 LIVE","description":" bioNtech Lunch symposium","account_id":"WxRD9M","ts":1607425200},"KEY04":{"id":"Wq1BQ1","strictid":"KEY04","name":"KEY04","description":"Melanie Saville","account_id":"WxRD9M","ts":1607425200},"SCS07":{"id":"27EaP3","strictid":"SCS07","name":"SCS07","description":"Influenza, RSV disease and COVID-19: clinical impact and diagnostic approaches (including disease management in primary healthcare and hospital settings)\n","account_id":"WxRD9M","ts":1607418000},"YSS01":{"id":"2bY8LM","strictid":"YSS01","name":"YSS01 LIVE","description":"Young Scientists at work LIVE","account_id":"WxRD9M","ts":1607418000},"GOM02":{"id":"VPryE6","strictid":"GOM02","name":"GOMO02 LIVE","description":"Goodmoring 2 with COLLIN","account_id":"WxRD9M","ts":1607414400},"MOR02":{"id":"Wx8qBy","strictid":"MOR02","name":"MORWEL02","description":"Morning Welcome Lecture Roche","account_id":"WxRD9M","ts":1607410800},"REC02":{"id":"VeB1l4","strictid":"REC02","name":"RECAP02 LIVE","description":"Recap of the day 07\/12\/2020\n","account_id":"WxRD9M","ts":1607369400},"MEE01":{"id":"21OlqM","strictid":"MEE01","name":"MEET01 LIVE","description":"Meet Collin and Ab 07\/12\/2020","account_id":"WxRD9M","ts":1607360400},"COM03":{"id":"Ww4KEx","strictid":"COM03","name":"COM03","description":"Company Lecture Keynote Cidara","account_id":"WxRD9M","ts":1607360400},"SCS06":{"id":"2a0aQy","strictid":"SCS06","name":"SCS06","description":"Innate and adaptive immune responses towards influenza, RSV disease and COVID-19 ","account_id":"WxRD9M","ts":1607360400},"SPI05":{"id":"A6PpOv","strictid":"SPI05","name":"SPI05","description":"Influenza, RSV disease and COVID-19 from a global health perspective, including underserved communities ","account_id":"WxRD9M","ts":1607360400},"SCS05":{"id":"2nyJwZ","strictid":"SCS05","name":"SCS05 LIVE","description":"Reservoirs for future pandemics LIVE ","account_id":"WxRD9M","ts":1607353200},"KEY03":{"id":"Wj19pg","strictid":"KEY03","name":"KEY03","description":"David Baauer","account_id":"WxRD9M","ts":1607353200},"SPI04":{"id":"24M6k4","strictid":"SPI04","name":"SPI04","description":"Influenza, RSV disease and COVID-19 intervention strategies: current practice and future strategies","account_id":"WxRD9M","ts":1607353200},"SCS04":{"id":"2OLdPK","strictid":"SCS04","name":"SCS04","description":"Viral and host factors in the pathogenesis of influenza, RSV disease and COVID-19 including genomics and big data ","account_id":"WxRD9M","ts":1607353200},"SAT03":{"id":"Vy8dbw","strictid":"SAT03","name":"SAT03 LIVE","description":"Live Satellite Janssen","account_id":"WxRD9M","ts":1607346000},"PEE02":{"id":"AK47ex","strictid":"PEE02","name":"PEEK02 LIVE","description":"","account_id":"WxRD9M","ts":1607338800},"COM02":{"id":"V3nMyY","strictid":"COM02","name":"COM02","description":"Company Lecture Janssen 2","account_id":"WxRD9M","ts":1607338800},"KEY02":{"id":"VBkg1g","strictid":"KEY02","name":"KEY02","description":"Johan Neyts","account_id":"WxRD9M","ts":1607338800},"SPI03":{"id":"VYZj4d","strictid":"SPI03","name":"SPI03","description":"why are influenza and RSV a priority for policy makers and what can learn from COVID-19 ","account_id":"WxRD9M","ts":1607338800},"SAT02":{"id":"VDxJvL","strictid":"SAT02","name":"SAT02 LIVE","description":"Influenza in persons living with diabetes. Pathogenesis and prevention","account_id":"WxRD9M","ts":1607331600},"GOM01":{"id":"W9bzne","strictid":"GOM01","name":"GOMO01 LIVE","description":"Goodmorning Coffee with Collin Russel","account_id":"WxRD9M","ts":1607328000},"MOR01":{"id":"WmdD95","strictid":"MOR01","name":"MORWEL01","description":"Morning Welcome 07\/12\/2020","account_id":"WxRD9M","ts":1607324400},"REC01":{"id":"VzXyk3","strictid":"REC01","name":"RECAP01","description":"Recap of the day 06\/12\/2020","account_id":"WxRD9M","ts":1607288400},"SAT07":{"id":"ApjEB0","strictid":"SAT07","name":"SAT07","description":"Astra Zeneca","account_id":"WxRD9M","ts":1607281200},"COM01":{"id":"2M4K31","strictid":"COM01","name":"COM01","description":"Company Lecture Janssen","account_id":"WxRD9M","ts":1607274000},"SCS03":{"id":"AZwZQG","strictid":"SCS03","name":"SCS03","description":"Virus structure and replication in influenza virus, RSV and SARS-CoV-2: latest developments in influenza virus, SARS-CoV-2 and RSV molecular virology ","account_id":"WxRD9M","ts":1607274000},"SPI02":{"id":"AQRkqN","strictid":"SPI02","name":"SPI02","description":"Benefits of vaccination of healthcare workers","account_id":"WxRD9M","ts":1607274000},"SAT01":{"id":"AG1B95","strictid":"SAT01","name":"SAT01 LIVE","description":"Seqirus Satellite Live","account_id":"WxRD9M","ts":1607266800},"PEE01":{"id":"ARXRdy","strictid":"PEE01","name":"PEEK01 LIVE","description":"","account_id":"WxRD9M","ts":1607263200},"KEY01":{"id":"WdEwYe","strictid":"KEY01","name":"KEY01","description":"Barbara Rath","account_id":"WxRD9M","ts":1607259600},"SCS02":{"id":"A0wZO7","strictid":"SCS02","name":"SCS02","description":"Epidemiology, surveillance and modelling of influenza, RSV disease and COVID-19, including virus evolution and strain selection ","account_id":"WxRD9M","ts":1607259600},"SCS01":{"id":"WN4q7v","strictid":"SCS01","name":"SCS01","description":"- viral and host factors in the transmission of influenza, RSV disease and COVID-19 including genomics and big data","account_id":"WxRD9M","ts":1607259600},"KEY07":{"id":"WEzPa4","strictid":"KEY07","name":"KEY07","description":"Zenghli SHI","account_id":"WxRD9M","ts":1607252400},"KEY06":{"id":"VPryB6","strictid":"KEY06","name":"KEY06","description":"Mike Ison","account_id":"WxRD9M","ts":1607252400},"SPI01":{"id":"Wq1Bee","strictid":"SPI01","name":"SPI01 LIVE","description":"How to join forces in influenza pandemic preparedness, what can we learn from COVID-19 stakeholder debate ","account_id":"WxRD9M","ts":1607252400},"OPN01":{"id":"27EaO9","strictid":"OPN01","name":"OPN01 LIVE","description":"Live Opening Ceremony","account_id":"WxRD9M","ts":1607245200}}
clevercast items
{"SCS03":{"id":"VeqK59","strictid":"SCS03","name":"SCS03_MASTER_CLEVERCAST_v01.mp4","description":"","account_id":"WxRD9M","chapters":[]},"KEY09":{"id":"2MLY8z","strictid":"KEY09","name":"KEY09","description":"Keynote Janina Krambach","account_id":"WxRD9M","chapters":[]},"COM03":{"id":"AZgx0j","strictid":"COM03","name":"COM03","description":"Company Keynote Cidara","account_id":"WxRD9M","chapters":[]},"SCS01":{"id":"WooQxg","strictid":"SCS01","name":"SCS01","description":"SCS 01- viral and host factors in the transmission of influenza, RSV disease and COVID-19 including genomics and big data","account_id":"WxRD9M","chapters":[]},"WEB01":{"id":"27jb0Z","strictid":"WEB01","name":"WEB01","description":"WEBINAR 1","account_id":"WxRD9M","chapters":[]},"WEB02":{"id":"WqOjo5","strictid":"WEB02","name":"WEB02","description":"WEBINAR 2","account_id":"WxRD9M","chapters":[]},"WEB03":{"id":"VyQaY9","strictid":"WEB03","name":"WEB03","description":"WEBINAR 3","account_id":"WxRD9M","chapters":[]},"WEB04":{"id":"2b73Dw","strictid":"WEB04","name":"WEB04","description":"Webinar 4","account_id":"WxRD9M","chapters":[]},"SCS02":{"id":"WxQprM","strictid":"SCS02","name":"SCS02","description":"SCS 02- Epidemiology, surveillance and modelling of influenza, RSV disease and COVID-19, including virus evolution and strain selection ","account_id":"WxRD9M","chapters":[]},"SPI07":{"id":"AJ1l01","strictid":"SPI07","name":"SPI07","description":"SPI 07 Burden of influenza, RSV disease and COVID-19 and impact on society","account_id":"WxRD9M","chapters":[{"position":138.679,"name":"Rebecca Cox"},{"position":778.62,"name":"Kathy Leung"},{"position":1431.473,"name":"John Paget"},{"position":2577.432,"name":"Susan C. Bolge"},{"position":3391.09,"name":"Miloje Savic"},{"position":3931.034,"name":"Jojanneke Van Summeren"}]},"SPI03":{"id":"WxQpKX","strictid":"SPI03","name":"SPI03","description":"SPI 03 - why are influenza and RSV a priority for policy makers and what can learn from COVID-19 ","account_id":"WxRD9M","ts":null},"KEY01":{"id":"VvQ67y","strictid":"KEY01","name":"KEY01","description":"Keynote Barbara Rath","account_id":"WxRD9M","ts":null},"KEY05":{"id":"W9j3ME","strictid":"KEY05","name":"KEY05","description":"Keynote Neil Ferguson","account_id":"WxRD9M","ts":null},"KEY07":{"id":"VeqKXQ","strictid":"KEY07","name":"KEY07","description":"Keynote ZHENGLI SHI","account_id":"WxRD9M","ts":null},"KEY04":{"id":"2nO4KR","strictid":"KEY04","name":"KEY04","description":"Keynote Melanie Saville","account_id":"WxRD9M","ts":null}}

Webinar: Influenza and RSV in a COVID-19 world

08:00 - 10:00

Chair 
Ab Osterhaus

Morning welcome lecture: Antiviral and Immune Modifiers for Treatment of Influenza, RSV and COVID-19

08:00 - 08:30

Speaker 
Michael Ison

Webinar: Clinical manifestations of Influenza, RSV and COVID-19

08:00 - 10:00

Chair 
Ab Osterhaus
Live

Good morning with Colin Russell

09:00 - 09:15

Morning welcome lecture: Host cell factors that impact the emergence of pandemic respiratory viruses

08:00 - 08:30

Speaker 
Wendy Barclay

Webinar: Intervention strategies for COVID-19, influenza and RSV

08:00 - 10:00

Chair 
Ab Osterhaus
Live

Good morning with Brooke Nichols

09:00 - 09:15

Meet the expert (sponsored by Roche): Strategies to Reduce Influenza Transmission – limited availability, registration required

09:00 - 09:30

Speakers 
Andreas Widmer
Leo Yi Yang Lee

Morning welcome lecture: Risk factors for severe outcomes following COVID-19 infection -results of a systematic literature review

08:00 - 08:15

Speaker 
Pasi Penttinen

Webinar: Cornerstones of pandemic preparedness and urgent actions

08:00 - 10:00

Chair 
Ab Osterhaus
Live

Good morning with Marco Goeijenbier

09:00 - 09:15

Meet the expert (sponsored by Roche): Management of Hospitalised Patients with Severe Influenza – limited availability, registration required

09:00 - 09:30

Speakers 
Tristan Clark
Jean-Paul Mira
Live

Opening ceremony

10:00 - 12:00

Live

Satellite symposium organised by the Influenza Diabetes Community, supported by Sanofi Pasteur: Influenza in persons living with diabetes. Pathogenesis and prevention

10:00 - 12:00

Chairs 
Marco Goeijenbier
Francesc Xavier Cos

Keynote lecture: COVID-19 vaccine development: where are we?

10:00 - 10:30

Speaker 
Melanie Saville

Influenza, RSV disease and COVID-19: clinical impact and diagnostic approaches (including disease management in primary healthcare and hospital settings)

10:00 - 12:00

Chairs 
Marco Goeijenbier
Tristan Clark
Live

Young Scientists at work

10:00 - 12:00

Chairs 
Ab Osterhaus
Gülsah Gabriel
Live

Satellite symposium organised by ESPID and ESWI. Should we introduce national live vaccination programmes for children?

10:00 - 12:00

Chair 
Terho Heikkinen

Keynote lecture: From SARS to COVID-19, understanding the interspecies transmission of SARS-related coronaviruses

12:00 - 12:30

Speaker 
Zhengli Shi
Live

How to join forces in influenza pandemic preparedness – what can we learn from COVID-19?

12:00 - 14:00

Chair 
Sylvie van der Werf

Special keynote lecture Janssen: Immunology underpinning vaccine strategy in COVID-19

12:00 - 12:30

Speaker 
Peter Openshaw

Keynote lecture: SARS-CoV2 : the hamster infection model, developing antiviral strategies and a unique single dose vaccine based on the yellow fever vaccine

12:00 - 12:30

Speaker 
Johan Neyts
Live

Poster Peek with Brooke Nichols

12:00 - 13:00

All you need to know about influenza, RSV disease and COVID-19

12:00 - 14:00

Chair 
Ab Osterhaus
Live

Satellite symposium organised by BioNTech: The Road to COVID-19 Vaccine Development

12:00 - 14:00

Keynote lecture: Transmission dynamics and control of COVID-19: what have we learned so far?

12:00 - 12:30

Speaker 
Neil Ferguson
Live

Poster Peek with Colin Russell

12:00 - 13:00

Animal influenza, ecology and epidemiology

12:00 - 14:00

Chairs 
Malik Peiris
Rodrigo Tapia

Influenza, RSV disease and COVID-19 vaccination: current and future approaches

12:00 - 14:00

Chairs 
Peter Openshaw
Dennis Lapuente

Keynote lecture: A shift in perspective: Understanding the patient experience of Influenza, COVID and RSV

14:00 - 14:30

Speaker 
Barbara Rath

Viral and host factors in the transmission of influenza, RSV disease and COVID-19, including genomics and big data

14:00 - 16:00

Chairs 
Ron Fouchier
Maria Auladell

Epidemiology, surveillance and modeling of influenza, RSV disease and COVID-19, including virus evolution and strain selection

14:00 - 16:00

Chairs 
Colin Russell
Bingyi Yang
Live

Poster Peek with Marco Goeijenbier

15:00 - 16:00

Live

Satellite symposium organised by Janssen: Addressing the ever-changing burden of RSV: The past, present and post COVID-19

14:00 - 16:00

Chair 
Peter Openshaw

Keynote lecture: Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards

14:00 - 14:30

Speaker 
Janina Krambrich
Live

Poster Peek with Colin Russell

14:00 - 15:00

Threats and risk management of epidemics and pandemics

14:00 - 16:00

Chairs 
Colin Russell
Ann Moen

Influenza, RSV disease and COVID-19 vaccination: current and future approaches

14:00 - 16:00

Chairs 
Barney Graham
Miruna Elena Rosu

Antiviral and immune therapy for influenza, RSV disease and COVID-19

14:00 - 16:00

Chairs 
Frederick Hayden
Joanne Mckenzie

Keynote lecture

14:00 - 14:30

Speaker 
Heidi Larson

Co-infections in influenza, RSV disease and COVID-19

14:00 - 16:00

Chair 
Ed Hutchinson

Risk evaluation and communication strategies in influenza and COVID-19: lessons learned

14:00 - 16:00

Chair 
Pasi Penttinen

Burden of influenza, RSV disease and COVID-19 and impact on society

14:00 - 16:00

Chairs 
Rebecca Cox
Kathy Sze Man Leung
Live

Satellite symposium organised by Seqirus: Strengthening influenza protection: Different needs, different solutions

16:00 - 18:00

Chair 
Joan Puig-Barberà

Keynote lecture: RNA Structure in Influenza and Coronaviruses: A Comparison

16:00 - 16:30

Speaker 
David LV Bauer

Viral and host factors in the pathogenesis of influenza, RSV disease and COVID-19, including genomics and big data

16:00 - 18:00

Chairs 
Barney Graham
Kirsty Short
Live

Reservoirs for future pandemics: threats from the animal world

16:00 - 18:00

Chairs 
Ab Osterhaus
Guha Asthagiri Arunkumar

Influenza, RSV disease and COVID-19 intervention strategies: current practice and future strategies

16:00 - 18:00

Chair 
Menno de Jong
Live

Satellite symposium organised by Roche: Can we stop flu going viral?

16:00 - 18:00

Chair 
Frederick Hayden
Live

Late Breakers: novel and outstanding scientific discoveries

16:00 - 18:00

Chair 
Mariette Ducatez

Special keynote lecture Janssen: Janssen’s efforts in the development of a COVID-19 vaccine

18:00 - 20:00

Speaker 
Hanneke Schuitemaker

Virus structure and replication in influenza virus, RSV and SARS-CoV-2; latest developments in influenza virus, SARS-CoV-2 and RSV molecular virology

18:00 - 20:00

Chairs 
Ervin Fodor
Aitor Nogales

Benefits of vaccination of healthcare workers

18:00 - 20:00

Chair 
Hanna Nohynek

Special keynote lecture Cidara Therapeutics: Beyond Vaccines and mAbs: Progress Towards Universal Influenza Protection with Cloudbreak® Influenza Antiviral Conjugates (AVCs)

18:00 - 18:30

Live

Meet Colin Russell and Marco Goeijenbier in the lounge

18:00 - 18:30

Innate and adaptive immune responses in influenza, RSV disease and COVID-19

18:00 - 20:00

Chairs 
Giuseppe Sautto
Guus Rimmelzwaan

Influenza, RSV disease and COVID-19 from a global health perspective, including underserved communities

18:00 - 20:00

Chair 
Marta Nunes
Live

Satellite symposium organised by Sanofi Pasteur: 10 years of evidence using high dose influenza vaccine in people age 65 and older

18:00 - 20:00

Chair 
Rosalind Hollingsworth
Live

Recap of the day: Highlights with Colin Russell, Marco Goeijenbier and Brooke Nichols

18:00 - 18:15

Live

Closing ceremony

18:15 - 19:00

Live

Satellite symposium organised by AstraZeneca: Targeting SARS-CoV-2: Novel vaccines and antivirals for the prevention and treatment of COVID-19

20:00 - 22:00

Live

Recap of the day: Highlights with Colin Russell and Ab Osterhaus

20:00 - 20:30

Live

Meet Colin Russell and Brooke Nichols in the lounge

20:00 - 20:30

Live

Recap of the day: Highlights with Colin Russell and Marco Goeijenbier

20:30 - 21:00

Live

Recap of the day: Highlights with Colin Russell and Brooke Nichols

22:00 - 22:30

  FILTER